Picture of BioForce Nanosciences Holdings logo

BFNH BioForce Nanosciences Holdings Income Statement

0.000.00%
us flag iconLast trade - 00:00
Consumer CyclicalsHighly SpeculativeSmall CapTurnaround

Annual income statement for BioForce Nanosciences Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue0.0040.0160.01800
Cost of Revenue
Gross Profit0.0010.0050.00400
Selling / General / Administrative Expenses
Total Operating Expenses0.0360.0830.0641580.502
Operating Profit-0.031-0.067-0.047-158-0.502
Other Net Non Operating Costs
Net Income Before Taxes-0.031-0.068-0.047-158-0.502
Provision for Income Taxes
Net Income After Taxes-0.031-0.068-0.047-158-0.502
Net Income Before Extraordinary Items
Net Income-0.031-0.068-0.047-158-0.502
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-0.031-0.068-0.047-158-0.502
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.002-0.004-0.003-9.72-0.017

Or unlock with your email

Or unlock with your email